Heart Transplant RecipientsCOMET-HTNCT07132554
Mixing 1:1 HIIT and MICT in Early to Very Early Phase HTx Recipients : a Retrospective Study From a 510 Patients/12 Years Database
An observational study of Heart Transplant Recipients, run by Hôpital Léon Bérard.
Trial summary
Background: Exercise-based cardiac rehabilitation is recommended early to very early for heart transplant recipients (HTRs), but data on its feasibility and efficacy at this stage are lacking. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Heart Transplant Recipients
- What is being tested?
- Combined 1:1 MICT and HIIT aerobic cardiac rehabilitation
- How many people
- 510 participants
- Where
- No sites listed yet
- Study dates
- 1 Dec 2012to 30 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: De novo HTR, after Heart failure from any etiology, at any age, from 3 University Transplantation units in the south-eastern quarter of France, admitted in our rehabilitation center for cardiac rehabilitation
Who may be able to join
- De Novo Heart Transplant Recipients (HTR)
Who cannot join
- None
About this study
Official title: Mixing 1:1 HIIT and MICT in Early to Very Early Phase Heart Transplant (HTx) Recipients : a Retrospective Study From a 510 Patients/12 Years Prospectively-collected Database
Background: Exercise-based cardiac rehabilitation is recommended early to very early for heart transplant recipients (HTRs), but data on its feasibility and efficacy at this stage are lacking. Primarily, this study reports the results of an intensive program combining moderate-intensity continuous-training (MICT) and high-intensity interval-training (HIIT) in early HTRs. Secondarily, it explores the determinants of VO2peak in this population.
Methods: A single-center retrospective study of a prospectively-collected database including patients who were consecutively referred to a cardiac rehabilitation unit immediately after discharge from acute post-transplant care, between December 2012 and December 2024. Patients participated in a tailored program combining MICT and HIIT as soon as they could cycle, and performed a first cardiopulmonary exercise test (CPET1) when possible. The initial prescription included 32 planned 30-minute (±5) aerobic sessions for 4 weeks, on a standard or semi-recumbent cycle-ergometer, twice a day (4 days a week) including one session of MICT (PVT and Borg-RPE 12-14) and one session of HIIT (6-8 x 1':3'/ PAT and Borg-RPE ≥ 15), plus additional sessions (respiratory and strengthening physiotherapy, gymnastics or walking, occupational therapy). The primary outcome was improvement in exercise capacity, measured by maximal oxygen consumption (VO2peak) between CPET1 and discharge (CPET2). Secondary outcomes included feasibility criterions (exercise-related adverse events-AE, and completion rates), then clinical, biological and echocardiographic parameters influencing exercise capacity.
Read the detailed description
INTRODUCTION The incidence and prevalence of heart failure (HF) are increasing globally. While its prevalence is estimated at 2% in developed countries, a similar upward trend has been observed in developing countries since the 2000s. This growing burden has led to a parallel rise in cases of advanced HF, a trend primarily driven by an aging population and improved patient survival rates. For patients with advanced HF and no contraindications, heart transplantation (HTx) remains the gold-standard treatment.
Concurrently, exercise capacity is a critical health indicator. In the general population, it is recognized as the strongest predictor of good health and survival, regardless of underlying pathologies. This importance is mirrored in heart transplant recipients (HTR), where enhanced exercise capacity is associated with improved functional status, better quality of life and lower re-hospitalization rates. Furthermore, emerging evidence suggests an inverse relationship with post-transplant mortality. For instance, a +14% increase in maximal oxygen consumption (VO2peak) has been estimated to yield a 32% reduction in mortality.
Exercise-based cardiac rehabilitation programs are the primary intervention for improving exercise capacity after HTx. Their effectiveness in increasing VO2peak was confirmed by a meta-analysis of nine randomized controlled trials (284 patients), the majority of which (n=8) utilized Moderate-Intensity Continuous Training (MICT), yielding a significant mean difference of +2.49 ml/kg/min (95% CI 1.69 to 3.49). However, these studies have limitations. With one exception from the smallest, the trials were conducted in the stable, chronic phase post-HTx (median 12 months) and exhibited significant heterogeneity in the type, volume, and intensity of aerobic exercise prescribed. Notably, despite being a major determinant of program effectiveness, patient adherence was not reported in any of these studies.
A few retrospective studies with small to medium sample sizes, more recently, the largest randomized controlled trial (n=81) to date have explored the effects of early cardiac rehabilitation. While these programs started between 2 and 3 months after HTx, few data exist on very early (≈1 month) standardized rehabilitation programs. In addition, if the ability of MICT to improve cardiorespiratory fitness (CRF) in HTx has been demonstrated, Nytroen et al. demonstrated the efficacy and safety of high-intensity interval training (HIIT) over MICT (SMD +1.8 mL/kg/min), in a long-term (9 months), high-volume (58 sessions x 25 minutes), high-intensity, good adherence, out-patient program.
Yet, recommendations still suggest starting at low intensity (≤50% VO2peak or -10% below the VO2ventilatory threshold), from the 2nd or 3rd post-operative week for the first few weeks, then increasing to MICT and then HIIT depending on tolerance, whereas HIIT should be introduced " only in the further course of clinically stable patient ". However, it may be that initial adherence to and enjoyment of exercise is a cornerstone of long-term physical activity maintenance Rodrigues, especially in the context of HF Klompstra. As described in other population, early in-center peer emulation and addressing the monotony of exercise programs seem important for improving initial management and long-term adherence.
The aim of this study is to report the feasibility and efficacy of an early to very early standardized mixed HIIT/MICT rehabilitation program in HTR implemented in routine care at our institution, as well as to explore some prognostic parameters related to early initial exercise capacity.
METHODS The study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent for their anonymized data to be used for research purposes. The study protocol was approved by the relevant institutional review board. The datasets used and/or analysed during the current study have been submitted to the editor. Data are available from the corresponding author on reasonable request.
2.1. Objectives The primary objective of this study was to evaluate the change in exercise capacity, measured by cardiopulmonary exercise testing, in heart transplant recipients between admission (CPET1) and discharge (CPET2) from an intensive mixed HIIT/MICT rehabilitation program. The secondary objective was to conduct an exploratory analysis to identify the determinants of exercise capacity in this population.
The primary endpoint was change in VO2peak between CPET1 and CPET2. The secondary endpoints were change between all other CPET parameters, and an exploratory analysis of the clinical, biological and echocardiographic determinants of exercise capacity.
2.2. Study Design and Population This retrospective cohort study was conducted using data from a single, specialized cardiac rehabilitation center (Hôpital Léon Bérard, Hyères, France). The investigators included all HTR (n=510) admitted between December 2012 and February 2023 for early inpatient rehabilitation. All participants were referred from three French university hospital transplant centers (CHU La Timone, Marseille; CHU Edouard Herriot, Lyon; and CHU Arnaud de Villeneuve, Montpellier) immediately after their acute post-surgical phase.
2.3. Data Collection Data were sourced from a local database created for this population in December 2012. The collection process was hybrid: data from December 2012 to June 2019 were extracted retrospectively from digitized medical records, whereas data from July 2019 onward were entered prospectively by the two attending cardiologists.
2.4. General process The general procedure for all admitted patients was prescribed and managed by two cardiologists, each with over two decades of experience, while daily field management was conducted by a dedicated team of physiotherapists and adapted physical activity (APA) instructors. All training sessions took place in an open-space environment under continuous cardiac monitoring and the direct supervision of an on-site cardiologist. The program included a comprehensive baseline assessment during the first week, comprising clinical data, routine biological parameters, a resting echocardiogram, and a cardiopulmonary exercise test (CPET1), repeated at discharge during the final week (CPET2). The 4-week intervention was structured around a high-frequency aerobic training regimen, complemented by a supplemental program adjusted for patient fatigue. The primary aerobic program, for patients able to perform CPET1, followed the FITT principle: Frequency of 8 sessions per week (twice daily, 4 days/week); Intensity prescribed in a target range between the first (VT₁) and second (VT₂) ventilatory thresholds; Time of 30 ± 5 minutes per session; and Type of exercise on a standard or semi-recumbent cycle ergometer. The supplemental program consisted of respiratory physiotherapy (4 sessions/week), resistance training (2 sessions/week, progressing from 30% to 50% of 1-RM), group activities such as outdoor walking or gymnastics (2 sessions/week), and occupational therapy. For patients unable to perform the CPET1, a modified protocol was implemented, typically involving one to two daily sessions of 15 to 30 minutes of moderate-intensity continuous training (MICT), with intensity guided by a Borg RPE of 12-14 on a semi-recumbent or arm ergometer. It should be noted that the subsequent analyses described in this paper pertain specifically to the cohort of patients who completed the baseline CPET.
2.5. Patient Assessment Protocol 2.5.1 Cardiopulmonary exercise testing The primary endpoint was the change in peak oxygen uptake (VO₂peak) from baseline to discharge.
Exercise capacity was assessed using a symptom-limited, incremental cardiopulmonary exercise test (CPET) performed on a standard or semi-recumbent cycle ergometer (ERGOLINE, Geispolsheim, France; or Corival CPET, Lode B.V., Groningen, The Netherlands). Each test began with a 2-minute warm-up (0-20 W) at a target cadence of 60 ± 10 rpm. Following the warm-up, an individualized ramp protocol was initiated, chosen from one of the following to target an optimal test duration of 8 ± 2 minutes:
An increment of 5 W/min after a 1-minute stage at 7 W (Corival ergometer protocol).
An increment of 5 W/min after a 1-minute stage at 20 W. An increment of 10 W/min after a 1-minute stage at 20 W. The test was continued until volitional exhaustion, with strong verbal encouragement provided. Test termination criteria adhered to the recommendations of the American College of Sports Medicine, and a 5- to 6-minute recovery period was systematically performed. A peak respiratory exchange ratio (RER) of ≥1.15 was considered the criterion for a maximal effort.
Gas exchange and ventilatory variables were measured on a breath-by-breath basis using a metabolic cart (METASYS TR-M, Brainware, La Valette du Var, France) and averaged every 15 seconds. Continuous 12-lead electrocardiography monitored heart rate (HR), while blood pressure was measured manually every two minutes.
The following specific parameters were selected for analysis:
Peak Exercise Values: Peak oxygen uptake (VO₂peak), defined as the highest VO₂ recorded; maximal power output (Pₘₐₓ); peak heart rate (HRₚₑₐₖ); peak minute ventilation (VEₚₑₐₖ); and the peak respiratory exchange ratio (RER).
Submaximal Thresholds: Values for VO₂, power (P), and HR were determined at the first and second ventilatory thresholds (VT₁ and VT₂, respectively).
Derived and Relative Parameters: The O₂ pulse (VO₂peak / HRₚₑₐₖ) was calculated. All absolute values for VO₂, P, and HR at peak exercise and at the ventilatory thresholds were also expressed as a percentage of their age-predicted norms based on the Wasserman equations.
2.4.2 6 min walk test
2.5. Rehabilitation program All rehabilitation sessions were conducted on an inpatient basis at the Hôpital Léon Bérard. Upon admission, each patient's comprehensive rehabilitation program was prescribed by a cardiologist and individually tailored based on their physical capacity, as determined by an initial physical therapy assessment and baseline cardiopulmonary exercise test (CPET1) results. The care of all heart transplant recipients (HTR) was specifically overseen by two dedicated cardiologists. The program consisted of twice-daily training sessions (morning and afternoon), five days a week (Monday to Friday), all conducted under the direct supervision of a physical therapist or a specialized Adapted Physical Activity (APA) instructor. For safety, a cardiologist was continuously available in close proximity to the training facility. As detailed in Table 1, the multi-component intervention integrated tailored endurance and resistance training, daily respiratory physiotherapy, collective physical activities, and a multi-faceted therapeutic education curriculum. A complete description of the specific protocols, intensity targets, session frequencies, and corresponding patient profiles for each intervention is provided in Table 1.
Table 1. Comprehensive Cardiac Rehabilitation Program Component / Activity Target Patient Profile Frequency Protocol / Details Endurance: Cycling / Ergoline Patients who can perform an CPET with no contraindication to cycling. 2 sessions / day (adjusted for fatigue) Session 1 (Moderate Intensity Continuous Training): 5 min warm-up + 25-40 min at aerobic threshold (VT1), maintaining a Borg scale rating of 12-14.
Session 2 (High intensity Interval Training - HIIT): 5 min warm-up + 24-38 min. Protocol: 1 min at anaerobic threshold (VT2) followed by 3 min recovery below VT1.
Endurance: Alternative Protocol Patients with very low capacity, or who have contraindications or an aversion to standard protocols.
1-2 sessions / day Moderate Intensity Continuous training: 15-30 min on Motomed (Borg 12-14) or treadmill (low/no incline, speed set to Borg 12-14); increasing if possible to HIIT at the end of the program.
Respiratory Physiotherapy All patients.
- session / day Performed on a therapy table. Focuses on diaphragmatic breathing and mobilizing respiratory volumes to counter the effects of sternotomy. Includes light limb strengthening (1-2 kg weights). Quadriceps Strengthening All patients, as soon as possible. 2-3 times / week Using a leg extension machine (3 sets of 10 reps).
- Week 1: 30% of 1-Repetition Maximum (1RM)
- Week 2: 40% of 1RM
- Week 3: 50% of 1RM Autonomy Rehabilitation Patients with a significant loss of autonomy. As needed Physiotherapy/Occupational therapy sessions for verticalization, transfers (e.g., wheelchair to table), and progressive rehabilitation for walking and climbing stairs. Individualized care following a functional neuromuscular and cognitive assessment. Group Gymnastics All patients, grouped by physical capacity.
- session / week
- Levels:
- Low Intensity: Seated exercises, transfer practice, balance.
- Moderate Intensity: Standing exercises, postural work, avoiding sternal stress.
- High Intensity: Standing exercises at a high pace with more repetitions. Group Walk All patients capable of walking on uneven ground.
2 session / week
Outdoor walk in the hospital park, split into two groups:
- Moderate: 1.1 km in 25 min (~2.6 km/h).
- Intense: 2.3 km in 34 min (~4.2 km/h).
Therapeutic Education: Medication All cardiac transplant patients. Scheduled workshop A group session on medication management, led by pharmacists. Therapeutic Education: Diet \& Nutrition All cardiac transplant patients. Throughout the stay Led by dietitians, program includes an initial assessment, an educational workshop, and a final assessment.
Therapeutic Education: Psychological Support All cardiac transplant patients. On demand \& scheduled Led by psychologists. Includes individual sessions, personality evaluation, and a support group (sometimes with a former transplant recipient).
Therapeutic Education: Transplant Info All cardiac transplant patients. Scheduled workshop "Understanding Your Cardiac Transplant," a workshop in small groups (3-5 patients) led by a clinician.
After the first CPET performed within the first week, the aerobic program consists of : i) a 30 (± 5) min MICT morning session at the power corresponding to the ventilatory threshold (PVT) ± 1 step, and monitored to correspond to a Borg-RPE 12-14 while progressing ; ii) a 24 to 36 min HIIT afternoon session, with 1 min interval at the power corresponding to the anaerobic threshold (PAT) ± 1 step, alternating with 3 min interval at ≤ 50% PVT, and monitored to correspond to a Borg-RPE ≥ 15 at the end of the session while progressing ; iii) All the other supplemental or non-aerobic exercises detailed in the general procedure.
When the AT is not reached/available during the first CPET, PVT +1 step is used initially and then adapted to the Borg-RPE scale.
A session is considered completed if 80% of the volume is made, at the targeted intensity.
Statistical analysis For the analysis, all patient data were reviewed exploratorily (exploratory database), but the primary "intention-to-treat" analysis was restricted to the "analytic database," comprising only patients who completed both admission and discharge CPETs (see Statistical Analysis section).
- Conditions
- Heart Transplant Recipients
- Being tested
- Combined 1:1 MICT and HIIT aerobic cardiac rehabilitation
- Keywords
- Exercise-based cardiac rehabilitation, VO2peak, Combine Moderate and Intense Training, Early-to-very-early phase post-HTx, Exercise capacity determinants
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Combined 1:1 MICT and HIIT aerobic cardiac rehabilitationOther
Combining 1:1 MICT and HIIT in short (4 weeks) high-volume (32 sessions) early-to-very-early phase program post heart transplantation
What is being measured
The primary outcome is the main question the study is designed to answer.
VO2peak
Main determinant of Exercise capacity, measured during a symptom-limited CardioPulmonary Exercise Test (CPET), performed in routine at our cardiac rehabilitation department
Measured: Baseline (Week 1) Discharge (Week 5)
Secondary outcomes (11)
VO2 vt/at
VO2 at the ventilatory threshold (VO2vt, ml/kg/min) VO2 at the anaerobic threshold (VO2at, ml/kg/min) during CPET
Measured: Baseline (Week 1) Discharge (Week 5)
Heart rate
Peak Heart Rate (HRpeak, bpm) Heart rate at rest (HRrest, bpm) HR at VO2vt (HRvo2vt, bpm) HR at VO2at (HRvo2at, bpm) Heart Rate Reserve, i.e HRpeak-HRrest (HRR, bpm) during CPET
Measured: Baseline (Week 1) Discharge (Week 5)
Power output
Maximum Work Power (Pmax, W) Work power at VT and AT (Pvt and Pat, W) during CPET
Measured: Baseline (Week 1) Discharge (Week 5)
O2pulse
VO2peak / HRpeak ratio (ml/kg/min/bpm), during CPET
Measured: Baseline (Week 1) Discharge (Week 5)
Echocardiography parameters
Ejection Fraction (%)
Measured: Baseline (Week 1) Discharge (Week 5)
Biological Parameters/Renal Failure
eGFR by CKD-EPI (mL/min per 1.73 m2 ) Renal Failure: e.g None or Mild (eGFR ≥ 60 mL/min) Moderate (30 ≤ eGFR < 59.9 mL/min) Severe (15 ≤ eGFR ≤ 29.9 mL/min) Terminal (eGFR < 15 mL/min)
Measured: Baseline (Week 1) Discharge (Week 5)
Clinical parameters
Sex (men)
Measured: Baseline (Week 1)
Clinical Parameters
Age (year)
Measured: Baseline (Week 1)
Clinical Parameters
BMI (kg/m²)
Measured: Baseline (Week 1) Discharge 'Week 5)
Clinical Parameters
Graft - Rehabilitation Center admission time (day) Lenght of hospital-stay in Rehabilitation department (day)
Measured: Baseline (Week 1) Discharge (Week 5)
Clinical Parameters
Etiology HF (%) (Dilated Cardiomyopathy- Ischaemic Cardiomyopathy- Congenital Cardiomyopathy- Hypertrophic Cardiomyopathy- Other Cardiomyopathy- ReGraft) ECMO (pre or post-HTx, %) Heartmate (%) Immunosuppressive medication (%) (Ciclosporine Tacrolimus Prednisolone)
Measured: Baseline (Week 1) Discharge (Week 5)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2025
- Study start1 Dec 2012
- Primary completion31 Dec 2024
- Study completion30 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart Transplant RecipientsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 510 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hôpital Léon Bérard
- Sponsor type
- University, hospital or other
- Collaborators
- Groupement des Hôpitaux de l'Institut Catholique de Lille, Centre Hospitalier Toulon
- Responsible party
- Principal investigator, Benjamin BERNUZ, MD, Hôpital Léon Bérard
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07132554
- Sponsor's protocol ID
- COMET-HT2012-2024
- Acronym
- COMET-HT
- Status last verified
- Aug 2025
- First submitted
- 22 Jul 2025
- Last updated
- 20 Aug 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Not enough time between end of data collection and open publication
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mixing 1:1 HIIT and MICT in Early to Very Early Phase Heart Transplant (HTx) Recipients : a Retrospective Study From a 510 Patients/12 Years Prospectively-collected Database
- ClinicalTrials.gov ID
- NCT07132554
- Acronym / sponsor ID
- COMET-HT / COMET-HT2012-2024
- Conditions
- Heart Transplant Recipients
- Keywords
- Exercise-based cardiac rehabilitation, VO2peak, Combine Moderate and Intense Training, Early-to-very-early phase post-HTx, Exercise capacity determinants
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 510 participants (actual)
- Lead sponsor
- Hôpital Léon BérardUniversity, hospital or other
- Collaborators
- Groupement des Hôpitaux de l'Institut Catholique de Lille, Centre Hospitalier Toulon
- Study start
- 1 Dec 2012 (actual)
- Primary completion
- 31 Dec 2024 (actual)
- Study completion
- 30 Jun 2025 (actual)
- First posted
- 20 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background: Exercise-based cardiac rehabilitation is recommended early to very early for heart transplant recipients (HTRs), but data on its feasibility and efficacy at this stage are lacking. Primarily, this study reports the results of an intensive program combining moderate-intensity continuous-training (MICT) and high-intensity interval-training (HIIT) in early HTRs. Secondarily, it explores the determinants of VO2peak in this population.
Methods: A single-center retrospective study of a prospectively-collected database including patients who were consecutively referred to a cardiac rehabilitation unit immediately after discharge from acute post-transplant care, between December 2012 and December 2024. Patients participated in a tailored program combining MICT and HIIT as soon as they could cycle, and performed a first cardiopulmonary exercise test (CPET1) when possible. The initial prescription included 32 planned 30-minute (±5) aerobic sessions for 4 weeks, on a standard or semi-recumbent cycle-ergometer, twice a day (4 days a week) including one session of MICT (PVT and Borg-RPE 12-14) and one session of HIIT (6-8 x 1':3'/ PAT and Borg-RPE ≥ 15), plus additional sessions (respiratory and strengthening physiotherapy, gymnastics or walking, occupational therapy). The primary outcome was improvement in exercise capacity, measured by maximal oxygen consumption (VO2peak) between CPET1 and discharge (CPET2). Secondary outcomes included feasibility criterions (exercise-related adverse events-AE, and completion rates), then clinical, biological and echocardiographic parameters influencing exercise capacity.
Detailed description
INTRODUCTION The incidence and prevalence of heart failure (HF) are increasing globally. While its prevalence is estimated at 2% in developed countries, a similar upward trend has been observed in developing countries since the 2000s. This growing burden has led to a parallel rise in cases of advanced HF, a trend primarily driven by an aging population and improved patient survival rates. For patients with advanced HF and no contraindications, heart transplantation (HTx) remains the gold-standard treatment.
Concurrently, exercise capacity is a critical health indicator. In the general population, it is recognized as the strongest predictor of good health and survival, regardless of underlying pathologies. This importance is mirrored in heart transplant recipients (HTR), where enhanced exercise capacity is associated with improved functional status, better quality of life and lower re-hospitalization rates. Furthermore, emerging evidence suggests an inverse relationship with post-transplant mortality. For instance, a +14% increase in maximal oxygen consumption (VO2peak) has been estimated to yield a 32% reduction in mortality.
Exercise-based cardiac rehabilitation programs are the primary intervention for improving exercise capacity after HTx. Their effectiveness in increasing VO2peak was confirmed by a meta-analysis of nine randomized controlled trials (284 patients), the majority of which (n=8) utilized Moderate-Intensity Continuous Training (MICT), yielding a significant mean difference of +2.49 ml/kg/min (95% CI 1.69 to 3.49). However, these studies have limitations. With one exception from the smallest, the trials were conducted in the stable, chronic phase post-HTx (median 12 months) and exhibited significant heterogeneity in the type, volume, and intensity of aerobic exercise prescribed. Notably, despite being a major determinant of program effectiveness, patient adherence was not reported in any of these studies.
A few retrospective studies with small to medium sample sizes, more recently, the largest randomized controlled trial (n=81) to date have explored the effects of early cardiac rehabilitation. While these programs started between 2 and 3 months after HTx, few data exist on very early (≈1 month) standardized rehabilitation programs. In addition, if the ability of MICT to improve cardiorespiratory fitness (CRF) in HTx has been demonstrated, Nytroen et al. demonstrated the efficacy and safety of high-intensity interval training (HIIT) over MICT (SMD +1.8 mL/kg/min), in a long-term (9 months), high-volume (58 sessions x 25 minutes), high-intensity, good adherence, out-patient program.
Yet, recommendations still suggest starting at low intensity (≤50% VO2peak or -10% below the VO2ventilatory threshold), from the 2nd or 3rd post-operative week for the first few weeks, then increasing to MICT and then HIIT depending on tolerance, whereas HIIT should be introduced " only in the further course of clinically stable patient ". However, it may be that initial adherence to and enjoyment of exercise is a cornerstone of long-term physical activity maintenance Rodrigues, especially in the context of HF Klompstra. As described in other population, early in-center peer emulation and addressing the monotony of exercise programs seem important for improving initial management and long-term adherence.
The aim of this study is to report the feasibility and efficacy of an early to very early standardized mixed HIIT/MICT rehabilitation program in HTR implemented in routine care at our institution, as well as to explore some prognostic parameters related to early initial exercise capacity.
METHODS The study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent for their anonymized data to be used for research purposes. The study protocol was approved by the relevant institutional review board. The datasets used and/or analysed during the current study have been submitted to the editor. Data are available from the corresponding author on reasonable request.
2.1. Objectives The primary objective of this study was to evaluate the change in exercise capacity, measured by cardiopulmonary exercise testing, in heart transplant recipients between admission (CPET1) and discharge (CPET2) from an intensive mixed HIIT/MICT rehabilitation program. The secondary objective was to conduct an exploratory analysis to identify the determinants of exercise capacity in this population.
The primary endpoint was change in VO2peak between CPET1 and CPET2. The secondary endpoints were change between all other CPET parameters, and an exploratory analysis of the clinical, biological and echocardiographic determinants of exercise capacity.
2.2. Study Design and Population This retrospective cohort study was conducted using data from a single, specialized cardiac rehabilitation center (Hôpital Léon Bérard, Hyères, France). The investigators included all HTR (n=510) admitted between December 2012 and February 2023 for early inpatient rehabilitation. All participants were referred from three French university hospital transplant centers (CHU La Timone, Marseille; CHU Edouard Herriot, Lyon; and CHU Arnaud de Villeneuve, Montpellier) immediately after their acute post-surgical phase.
2.3. Data Collection Data were sourced from a local database created for this population in December 2012. The collection process was hybrid: data from December 2012 to June 2019 were extracted retrospectively from digitized medical records, whereas data from July 2019 onward were entered prospectively by the two attending cardiologists.
2.4. General process The general procedure for all admitted patients was prescribed and managed by two cardiologists, each with over two decades of experience, while daily field management was conducted by a dedicated team of physiotherapists and adapted physical activity (APA) instructors. All training sessions took place in an open-space environment under continuous cardiac monitoring and the direct supervision of an on-site cardiologist. The program included a comprehensive baseline assessment during the first week, comprising clinical data, routine biological parameters, a resting echocardiogram, and a cardiopulmonary exercise test (CPET1), repeated at discharge during the final week (CPET2). The 4-week intervention was structured around a high-frequency aerobic training regimen, complemented by a supplemental program adjusted for patient fatigue. The primary aerobic program, for patients able to perform CPET1, followed the FITT principle: Frequency of 8 sessions per week (twice daily, 4 days/week); Intensity prescribed in a target range between the first (VT₁) and second (VT₂) ventilatory thresholds; Time of 30 ± 5 minutes per session; and Type of exercise on a standard or semi-recumbent cycle ergometer. The supplemental program consisted of respiratory physiotherapy (4 sessions/week), resistance training (2 sessions/week, progressing from 30% to 50% of 1-RM), group activities such as outdoor walking or gymnastics (2 sessions/week), and occupational therapy. For patients unable to perform the CPET1, a modified protocol was implemented, typically involving one to two daily sessions of 15 to 30 minutes of moderate-intensity continuous training (MICT), with intensity guided by a Borg RPE of 12-14 on a semi-recumbent or arm ergometer. It should be noted that the subsequent analyses described in this paper pertain specifically to the cohort of patients who completed the baseline CPET.
2.5. Patient Assessment Protocol 2.5.1 Cardiopulmonary exercise testing The primary endpoint was the change in peak oxygen uptake (VO₂peak) from baseline to discharge.
Exercise capacity was assessed using a symptom-limited, incremental cardiopulmonary exercise test (CPET) performed on a standard or semi-recumbent cycle ergometer (ERGOLINE, Geispolsheim, France; or Corival CPET, Lode B.V., Groningen, The Netherlands). Each test began with a 2-minute warm-up (0-20 W) at a target cadence of 60 ± 10 rpm. Following the warm-up, an individualized ramp protocol was initiated, chosen from one of the following to target an optimal test duration of 8 ± 2 minutes:
An increment of 5 W/min after a 1-minute stage at 7 W (Corival ergometer protocol).
An increment of 5 W/min after a 1-minute stage at 20 W. An increment of 10 W/min after a 1-minute stage at 20 W. The test was continued until volitional exhaustion, with strong verbal encouragement provided. Test termination criteria adhered to the recommendations of the American College of Sports Medicine, and a 5- to 6-minute recovery period was systematically performed. A peak respiratory exchange ratio (RER) of ≥1.15 was considered the criterion for a maximal effort.
Gas exchange and ventilatory variables were measured on a breath-by-breath basis using a metabolic cart (METASYS TR-M, Brainware, La Valette du Var, France) and averaged every 15 seconds. Continuous 12-lead electrocardiography monitored heart rate (HR), while blood pressure was measured manually every two minutes.
The following specific parameters were selected for analysis:
Peak Exercise Values: Peak oxygen uptake (VO₂peak), defined as the highest VO₂ recorded; maximal power output (Pₘₐₓ); peak heart rate (HRₚₑₐₖ); peak minute ventilation (VEₚₑₐₖ); and the peak respiratory exchange ratio (RER).
Submaximal Thresholds: Values for VO₂, power (P), and HR were determined at the first and second ventilatory thresholds (VT₁ and VT₂, respectively).
Derived and Relative Parameters: The O₂ pulse (VO₂peak / HRₚₑₐₖ) was calculated. All absolute values for VO₂, P, and HR at peak exercise and at the ventilatory thresholds were also expressed as a percentage of their age-predicted norms based on the Wasserman equations.
2.4.2 6 min walk test
2.5. Rehabilitation program All rehabilitation sessions were conducted on an inpatient basis at the Hôpital Léon Bérard. Upon admission, each patient's comprehensive rehabilitation program was prescribed by a cardiologist and individually tailored based on their physical capacity, as determined by an initial physical therapy assessment and baseline cardiopulmonary exercise test (CPET1) results. The care of all heart transplant recipients (HTR) was specifically overseen by two dedicated cardiologists. The program consisted of twice-daily training sessions (morning and afternoon), five days a week (Monday to Friday), all conducted under the direct supervision of a physical therapist or a specialized Adapted Physical Activity (APA) instructor. For safety, a cardiologist was continuously available in close proximity to the training facility. As detailed in Table 1, the multi-component intervention integrated tailored endurance and resistance training, daily respiratory physiotherapy, collective physical activities, and a multi-faceted therapeutic education curriculum. A complete description of the specific protocols, intensity targets, session frequencies, and corresponding patient profiles for each intervention is provided in Table 1.
Table 1. Comprehensive Cardiac Rehabilitation Program Component / Activity Target Patient Profile Frequency Protocol / Details Endurance: Cycling / Ergoline Patients who can perform an CPET with no contraindication to cycling. 2 sessions / day (adjusted for fatigue) Session 1 (Moderate Intensity Continuous Training): 5 min warm-up + 25-40 min at aerobic threshold (VT1), maintaining a Borg scale rating of 12-14.
Session 2 (High intensity Interval Training - HIIT): 5 min warm-up + 24-38 min. Protocol: 1 min at anaerobic threshold (VT2) followed by 3 min recovery below VT1.
Endurance: Alternative Protocol Patients with very low capacity, or who have contraindications or an aversion to standard protocols.
1-2 sessions / day Moderate Intensity Continuous training: 15-30 min on Motomed (Borg 12-14) or treadmill (low/no incline, speed set to Borg 12-14); increasing if possible to HIIT at the end of the program.
Respiratory Physiotherapy All patients.
- session / day Performed on a therapy table. Focuses on diaphragmatic breathing and mobilizing respiratory volumes to counter the effects of sternotomy. Includes light limb strengthening (1-2 kg weights). Quadriceps Strengthening All patients, as soon as possible. 2-3 times / week Using a leg extension machine (3 sets of 10 reps).
- Week 1: 30% of 1-Repetition Maximum (1RM)
- Week 2: 40% of 1RM
- Week 3: 50% of 1RM Autonomy Rehabilitation Patients with a significant loss of autonomy. As needed Physiotherapy/Occupational therapy sessions for verticalization, transfers (e.g., wheelchair to table), and progressive rehabilitation for walking and climbing stairs. Individualized care following a functional neuromuscular and cognitive assessment. Group Gymnastics All patients, grouped by physical capacity.
- session / week
- Levels:
- Low Intensity: Seated exercises, transfer practice, balance.
- Moderate Intensity: Standing exercises, postural work, avoiding sternal stress.
- High Intensity: Standing exercises at a high pace with more repetitions. Group Walk All patients capable of walking on uneven ground.
2 session / week
Outdoor walk in the hospital park, split into two groups:
- Moderate: 1.1 km in 25 min (~2.6 km/h).
- Intense: 2.3 km in 34 min (~4.2 km/h).
Therapeutic Education: Medication All cardiac transplant patients. Scheduled workshop A group session on medication management, led by pharmacists. Therapeutic Education: Diet \& Nutrition All cardiac transplant patients. Throughout the stay Led by dietitians, program includes an initial assessment, an educational workshop, and a final assessment.
Therapeutic Education: Psychological Support All cardiac transplant patients. On demand \& scheduled Led by psychologists. Includes individual sessions, personality evaluation, and a support group (sometimes with a former transplant recipient).
Therapeutic Education: Transplant Info All cardiac transplant patients. Scheduled workshop "Understanding Your Cardiac Transplant," a workshop in small groups (3-5 patients) led by a clinician.
After the first CPET performed within the first week, the aerobic program consists of : i) a 30 (± 5) min MICT morning session at the power corresponding to the ventilatory threshold (PVT) ± 1 step, and monitored to correspond to a Borg-RPE 12-14 while progressing ; ii) a 24 to 36 min HIIT afternoon session, with 1 min interval at the power corresponding to the anaerobic threshold (PAT) ± 1 step, alternating with 3 min interval at ≤ 50% PVT, and monitored to correspond to a Borg-RPE ≥ 15 at the end of the session while progressing ; iii) All the other supplemental or non-aerobic exercises detailed in the general procedure.
When the AT is not reached/available during the first CPET, PVT +1 step is used initially and then adapted to the Borg-RPE scale.
A session is considered completed if 80% of the volume is made, at the targeted intensity.
Statistical analysis For the analysis, all patient data were reviewed exploratorily (exploratory database), but the primary "intention-to-treat" analysis was restricted to the "analytic database," comprising only patients who completed both admission and discharge CPETs (see Statistical Analysis section).
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- De novo HTR, after Heart failure from any etiology, at any age, from 3 University Transplantation units in the south-eastern quarter of France, admitted in our rehabilitation center for cardiac rehabilitation
Key inclusion criteria (1 listed)
- De Novo Heart Transplant Recipients (HTR)
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Combined 1:1 MICT and HIIT aerobic cardiac rehabilitationCombining 1:1 MICT and HIIT in short (4 weeks) high-volume (32 sessions) early-to-very-early phase program post heart transplantation | Other | – |
Primary outcome
VO2peak
Time frame: Baseline (Week 1) Discharge (Week 5)
Main determinant of Exercise capacity, measured during a symptom-limited CardioPulmonary Exercise Test (CPET), performed in routine at our cardiac rehabilitation department
11 secondary outcomes
VO2 vt/at
Time frame: Baseline (Week 1) Discharge (Week 5)
Heart rate
Time frame: Baseline (Week 1) Discharge (Week 5)
Power output
Time frame: Baseline (Week 1) Discharge (Week 5)
O2pulse
Time frame: Baseline (Week 1) Discharge (Week 5)
Echocardiography parameters
Time frame: Baseline (Week 1) Discharge (Week 5)
Biological Parameters/Renal Failure
Time frame: Baseline (Week 1) Discharge (Week 5)
Clinical parameters
Time frame: Baseline (Week 1)
Clinical Parameters
Time frame: Baseline (Week 1)
Clinical Parameters
Time frame: Baseline (Week 1) Discharge 'Week 5)
Clinical Parameters
Time frame: Baseline (Week 1) Discharge (Week 5)
Clinical Parameters
Time frame: Baseline (Week 1) Discharge (Week 5)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2025.
- Individual participant dataSharing planned: Undecided. Not enough time between end of data collection and open publication
Related trials for Heart Transplant Recipients
Recruiting
Multidisciplinary Non-Pharmacological Intervention to Improve Quality of Life in Solid Organ Transplant Recipients
Heart Transplant Patients, Kidney Transplant Patients
Active, not recruiting
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
Chronic Heart Failure, Heart Transplant Recipient
Enrolling by invitationObservational study
Donor Derived Cell Free DNA (Dd-cfDNA) as a Biomarker for Allograft Rejection in Heart Transplant Recipients
Heart Transplantation
RecruitingObservational study
Vascular Complications After Kidney Transplantation
Kidney Transplant Recipient, Kidney Transplant; Complications
RecruitingPhase 2
Belatacept in Heart Transplantation
Heart Transplant
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Heart Transplant Recipients, run by Hôpital Léon Bérard.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
VO2peak (time frame: Baseline (Week 1) Discharge (Week 5)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.